Dr. Johann Brandes MD, PHD

Expert Publications

• Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the literature.
• Occlusive endobronchial stent placement as a novel management approach to massive hemoptysis from lung cancer.
• Cancer DNA methylation: molecular mechanisms and clinical implications.
• Targeted therapy of non-small-cell lung carcinoma.
• CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
• Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
• Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer.
• Could valproic acid be an effective anticancer agent? The evidence so far.
• Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC.
• Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.
• Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer.

Media Releases

Get to know Oncologist Dr. Johann Brandes, who serves the population of Tennessee. Dr. Brandes is tri-certified and fellowship trained oncologist. He holds certification in Internal Medicine, Medical Oncology, and Critical Care Medicine by the American Board of Internal Medicine. Since its founding in 1936 to answer a public call to establish more uniform standards for physicians, Certification by the American Board of Internal Medicine (ABIM) has stood for the highest standard in internal medicine and its 20 subspecialties. Certification has meant that internists have demonstrated – to their peers and to the public – that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care. Dr. Brandes currently practices as an Oncologist with Tennessee Oncology, and is affiliated with St Thomas Hospital in Rutherford, Tennessee, where he holds an expertise in Thorasic Oncology. Tennessee Oncology, one of the nation’s largest, community-based cancer care specialists, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology’s mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home. Their growing network of physicians and locations is based on this mission. Dr. Brandes graduated with his Medical Degree from the University of Munich in Germany in 1998, giving him over two decades of experience in his field. After obtaining his Medical Degree he completed his residency with the Humboldt University Berlin in Germany. He then relocated to the United States and completed his internal medicine residency with the John Hopkins Hospital. Wanting to further his training he then completed his Medical Oncology and Pulmonary Disease and Critical Care Medicine Fellowship with the John Hopkins Hospital. To stay up to date in his field he remains a professional member of the American Society of Clinical Oncology and the American College of Chest Physicians and has been inducted as a Fellow of the American College of St Thomas. Oncology is a branch of medicine that deals with the diagnosis, treatment or prevention of cancer. The specialist who practices oncology is known as an oncologist. If an oncologist has special training in performing surgery on cancerous tumors, he or she is called a surgical oncologist. Dr. Brandes attributes his professional success to his hard work and diligence.

Recommended Articles

• Teen Battling Lymphoma Uses Her Make-a-Wish to do the Kindest Gesture Ever!

  In November of 2017, 13-year-old Brooklyn Gallagher began experiencing what appeared to be symptoms of an upper respiratory infection. Initially, her mother, Tiffany Divicenzo, thought that it was merely a common cold. However, as Brooklyn’s symptoms began to worsen, her lymph nodes began to swell...

• How Is Bladder Cancer Diagnosed?

  In case you have symptoms of bladder cancer such as the presence of blood in the urine, you should see your doctor immediately. Your doctor will use many tests to possibly diagnose a bladder cancer and will also find out how far it has spread. Sometimes, bladder cancer may have spread to other parts...

• Lymphoma GoFundMe Success Stories

  When a community or group of friends bands together to help one another, miracles happen. There is nothing more humbling than seeing a community take time of their own to help a friend or community member in need. The more people there are, the bigger difference they can make. There are hundreds of...

• New Advancement to Reduce Rate of Breast Cancer Spreading

  One of the most difficult aspects of treating cancer is fighting against the speed at which the cancer spreads throughout the body. As cells grow and multiply, they begin to affect larger systems in the body, and can metastasize to different systems entirely. Once a cancer has spread from the...

• What Impact Does Hospital Volume Have on Ovarian Cancer Survival?

  Ovarian cancer is one of the most difficult cancers to treat. Though overall survival is generally over 90% if caught early, only about 15% of ovarian cancers are diagnosed at early stages. This means that many women are diagnosed with ovarian cancer at more advanced stages with high mortality.With...

• Treatments for Bladder Cancer

  The treatment options or medications for bladder cancer depend largely on the advancement of cancer. The treatment is different for the early stage non-invasive bladder cancer and the more advanced muscle-invasive bladder cancer.During treatment, all hospitals have multidisciplinary teams (MDTs),...